Eli Lilly and Company (NYSE: LLY) Q2 2021 earnings call dated Aug. 03, 2021 Corporate Participants: Kevin Hern -- Investor Relations David A. Ricks -- Chairman
Eli Lilly and Company
-(LLY)
Get the latest Eli Lilly and Company (LLY) stock news, earnings analysis, earnings conference calls, earnings transcripts from AlphaStreet.
Earnings calendar for the week of August 2
Labor market conditions improved once again and jobless claims dropped to about 400,000 after rising last week, as economic activity picked up.
LLY Stock: Is Eli Lilly a good bet in COVID-challenged healthcare market?
For pharmaceutical companies, 2020 was a busy year when the healthcare sector went into overdrive to deal with the challenges posed by
Eli Lilly and Company (LLY) Q1 2021 Earnings Call Transcript
Eli Lilly and Company (NYSE: LLY) Q1 2021 earnings call dated Apr. 27, 2021 Corporate Participants: Kevin Hern -- Vice President, Investor Relations David A.
Earnings calendar for the week of April 26
Investor sentiment was hit by the government's proposal to levy higher capital gain tax on wealthy individuals, and the market shifted to
Eli Lilly & Co (LLY) Q4 2020 Earnings Call
Eli Lilly & Co (NYSE: LLY) Q4 2020 earnings call dated Jan. 29, 2021 Corporate Participants: Kevin Hern — Vice President of Investor Relations David
Where do these companies stand in the COVID-19 vaccine race?
After the struggle with the COVID-19 pandemic and its impacts clouding most of 2020, the rollout of vaccines against COVID-19 is the
Eli Lilly & Co (LLY) Q4 2020 Earnings Call Transcript
Eli Lilly & Co (NYSE: LLY) Q4 2020 earnings call dated Jan. 29, 2021 Corporate Participants: Kevin Hern -- Vice President of Investor Relations
Earnings calendar for the week of January 25
Leading stock indices continued the recent rally this week, with S&P 500 and Dow Jones Industrial Average setting new records helped mainly
Latest study shows Eli Lilly’s (LLY) antibody reduces COVID-19 by 80%
Eli Lilly and Company (NYSE: LLY) announced that the results from its latest study indicated that its monoclonal antibody bamlanivimab reduced the
Eli Lilly (LLY) is paving the way to a strong 2021
Shares of Eli Lilly & Co. (NYSE: LLY) were up over 2% on Wednesday. The stock has gained over 30% since the
COVID-19 vaccine: These pharma companies have also made headway
The month of November has been huge for pharmaceutical companies with many submitting positive results from their clinical trials for the development
Eli Lilly and Company (LLY) Q3 2020 Earnings Call Transcript
Eli Lilly and Company (NYSE : LLY) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Kevin Hern -- Vice President, Investor Relations
Eli Lilly & Co. (LLY) Q2 2020 Earnings Call Transcript
Eli Lilly & Co. (NYSE: LLY) Q2 2020 earnings call dated July 30, 2020 https://www.youtube.com/watch?v=d4-cSFo067A Presentation: Operator Ladies and gentlemen, thank you
LLY Earnings: All you need to know about Eli Lilly Q2 2020 earnings results
Eli Lilly and Company (NYSE: LLY) reported second quarter 2020 earnings results today. Revenues declined 2% year-over-year to $5.4 billion. Reported net
Eli Lilly (LLY) appears to be on a strong footing with COVID-19 drug development efforts
Eli Lilly & Co.’s (NYSE: LLY) shares have gained 29% since the beginning of the year and 16% over the past three
Eli Lilly & Co (NYSE: LLY) Q1 2020 Earnings Call Transcript
Eli Lilly & Co (LLY) Q1 2020 earnings call dated Apr. 23, 2020 Corporate Participants: Kevin Hern -- Vice President, Investor Relations David A.
Eli Lilly (LLY) reports Q1 2020 earnings results
Pharmaceutical company Eli Lilly (NYSE: LLY) reported first quarter 2020 revenue of $5.86 billion, up 15% year-over-year. Amid COVID-19 pandemic, the company
Eli Lilly & Co (NYSE: LLY) Q4 2019 Earnings Call Transcript
Eli Lilly & Co (NYSE: LLY) Q4 2019 Earnings Conference Call January 30, 2020 Corporate Participants: Kevin Hern -- Vice President of Investor Relations David
Eli Lilly beats Q3 earnings expectations; revenues miss estimates
Eli Lilly and Company (NYSE: LLY) surpassed earnings expectations for the third quarter of 2019 but revenues came in shy of estimates.
Eli Lilly Q2 profit beats estimates, lifts FY19 forecast
Eli Lilly and Company (NYSE: LLY) swung to a profit in the second quarter of 2019 from a loss last year, helped